This is a limited company view. Sign up for a Free Trial to see everything.

BioAegis Therapeutics develops novel protein replacement therapies targeted at saving lives based on the endogenous human protein, plasma gelsolin (pGSN).

B2B
Biotechnology
Cleantech
Healthcare
Pharmaceuticals
Wind Power

Overview

Location

New York

Founded

2011

Employees

8

Stage

Late

Total funding

$7M

Last funding

4 years ago

Acquisitions

0

Growth score

10

Mindshare score

7

Scoring

Deals

$3.7M Debt

Feb 7, 2014

$3.0M Seed

Feb 8, 2013

Employee Growth

Use BioAegis Therapeutics's historical employee count to better understand their growth and spending over time.

Unlock with a Free Trial

Mobile

Use BioAegis Therapeutics's mobile downloads and app ranks to evaluate the performance of their mobile apps.

Unlock with a Free Trial

Key People

Scientist
Scientist
Investor
Diagnostics Expert

Similar Companies

Alios BioPharma

Explore Janssen's innovative medical research and development practices, and see how Janssen is dedicated to the well-being of patients around the world.
Acquired|89 employees

Gain context with Mattermark Salesforce Enrichment

Find out how

Notes